Sard Verbinnen & Co. is handling Veritas Capital’s $5.7B deal ($135 per-share) for Athenahealth, which provides technology services for hospital and ambulatory companies.
 |
The transaction calls for Elliott Management Corp’s Evergreen Coast Capital unit to be a minority investor in the combination of Athena and Veritas-backed Virence Health, the GE Healthcare unit that Veritas acquired in July for $1.1B.
Elliott, which controls a nine percent stake in Athena, offered to offered to buy the company for $160 per-share in May.
The Financial Times notes the Athena deal is the largest-ever for Veritas, which has $10B in assets under management.
Jeff Immelt, former GE CEO and executive chairman of Athena, expects private ownership will benefit his Watertown (MA)-based company via “increased flexibility to achieve our purpose of unleashing our collective potential to transform healthcare.”
SV&C’s Andrew Cole, David Millar and Julie Rudnick represent Veritas, while Athena relies on Joele Frank, Wilkinson Brimmer Katcher’s Barrett Golden, Nick Lamplough and Scott Bisang.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
